Therapeutic plasma exchange and intravenous immune globulin in the treatment of heparin-induced thrombocytopenia: A systematic review.

Chinonso OnuohaKaren D BartonEdward C C WongJay S RavalMarian A Rollins-RavalTina S IpeJoseph E KissLeonard I BoralJill AdamskiNicole D ZantekOluwatoyosi Adefunke Onwuemene

Published in: Transfusion (2020)

In patients with HIT, both TPE and IVIG are used for initial therapy or treatment of refractory HIT. However, TPE is more commonly used in patients undergoing CPB. Prospective studies may help clarify which treatment is indicated in HIT population subsets.

Keyphrases

patients undergoing
venous thromboembolism
low dose
oxidative stress
high dose
mesenchymal stem cells
smoking cessation